OPKO Health (OPK) Stock: Climbing On Clinical Data
OPKO Health Inc. (NASDAQ: OPK) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced positive results from a phase 2 clinical trial, exciting investors who are pushing the stock for the top. Today, we’ll talk about: The clinical data; what we’re seeing from OPK stock … Read more